Efficacy and safety of rituximab for autoimmune neutropenia: a French case series and literature review-Reference-Cited by-同舟云学术

Efficacy and safety of rituximab for autoimmune neutropenia: a French case series and literature review

Published:2020-02-21 Issue:9 Volume:59 Page:2637-2640
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Bigot William¹²,Viallard Jean Francois³,Sellam Jérémie¹,Dellal Azeddine⁴,Retbi Aurélie⁵,Gobert Delphine¹,Malard Florent⁴,Mohty Mohamad⁴,Mekinian Arsène¹,Fain Olivier¹

Affiliation:

1. Service de Médecine Interne et Inflammation-Immunopathology-Biotherapy Department, Sorbonne Université, AP-HP, Hôpital Saint-Antoine

2. Département Hospitalo-Universitaire Inflammation-Immunopathologie-Biotherapie (DHU i2B), Paris

3. Service de Médecine Interne et Immunologie Clinique, CHU Bordeaux, Bordeaux

4. Service de Rhumatologie, Hôpital Montfermeil, Monfermeil

5. Hôpital Saint Antoine, Sorbonne Universités, AP-HP, Paris, France

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/59/9/2637/33686163/keaa045.pdf

Reference21 articles.

1. Autoimmune neutropenia in adults;Akhtari;Autoimmun Rev,2009

2. Severe chronic primary neutropenia in adults: report on a series of 108 patients;Sicre de Fontbrune;Blood,2015

3. Primary and secondary autoimmune neutropenia;Capsoni;Arthritis Res Ther,2005

4. Beneficial response to rituximab in refractory Felty syndrome;Weinreb;J Clin Rheumatol,2006

5. Efficacy of rituximab in Felty’s syndrome;Shipley;Joint Bone Spine,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical presentation of Felty syndrome: Successful management with rituximab therapy—A case report and review of literature;Clinical Case Reports;2024-08

2. T-cell large granular lymphocytic leukaemia in rheumatoid arthritis;BMJ Case Reports;2024-08

3. Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases;The FASEB Journal;2024-03-12

4. Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases;2023-09-25

5. Autoimmune Neutropenias: Update on Clinical and Biological Features in Children and Adults;HemaSphere;2022-12-19